BofA raised the firm’s price target on Eastman Chemical (EMN) to $75 from $74 and keeps a Buy rating on the shares. 2026 earnings tailwinds such as cost savings and an asset utilization ramp are material enough to lead to earnings improvement from 2025, even if end-market demand remains sluggish and the company continues to focus on cash generation at the expense of profits, the analyst tells investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
